Practical guidance for national influenza centres establishing or implementing neuraminidase inhibitor susceptibility surveillance

updated 2018

Overview

This document discusses the practical considerations that must be assessed when deciding whether implementation of AVST within a laboratory is practical, the long-term costs of testing, and the requirements for testing in terms of resources (both equipment and reagents) and staff training.

WHO Team
Global Influenza Programme (GIP), Global Influenza Surveillance and Response System
Number of pages
21
Reference numbers
ISBN: 978-92-4-151666-2